γδ T cells in cancer
The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Abstract
With the promise of T cell-based therapy for cancer finally becoming reality, this Review focuses on the less-studied γδ T cell lineage and its diverse responses to tumours. γδ T cells have well-established protective roles in cancer, largely on the basis of their potent cytotoxicity and interferon-γ production. Besides this, recent studies have revealed a series of tumour-promoting functions that are linked to interleukin-17-producing γδ T cells. Here, we integrate the current knowledge from both human and mouse studies to highlight the potential of γδ T cell modulation to improve cancer immunotherapy.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“γδ T cells can have either protective roles or tumor-promoting functions in cancer; tumor-promoting activities of γδ T cells have been ascribed to distinct mechanisms in different types of cancers (Daley et al., 2016; Silva-Santos et al., 2015).”
From Commensal Microbiota Promote Lung Cancer Development via γδ T Cells (2019) · cites this paper as Silva-Santos et al., 2015
Citations
Cites
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Neoantigens in cancer immunotherapy
Schumacher, T. N., & Schreiber, R. D. (2015) · Science · doi:10.1126/science.aaa4971 · Cited by 4,783
Coordinated regulation of myeloid cells by tumours
Gabrilovich, D. I., Ostrand-Rosenberg, S., & Bronte, V. (2012) · Nature Reviews Immunology · doi:10.1038/nri3175 · Cited by 3,544
The prognostic landscape of genes and infiltrating immune cells across human cancers
Gentles, A. J., Newman, A. M., Liu, C. L., Bratman, S. V., Feng, W., Kim, D., Nair, V. S., Xu, Y., Khuong, A., Hoang, C. D., et al. (2015) · Nature Medicine · doi:10.1038/nm.3909 · Cited by 3,118
Inflammation-induced cancer: Crosstalk between tumours, immune cells and microorganisms
Elinav, E., Nowarski, R., Thaiss, C. A., Hu, B., Jin, C., & Flavell, R. A. (2013) · Nature reviews. Cancer · doi:10.1038/nrc3611 · Cited by 2,000
IL-17-producing γδ T cells and neutrophils conspire to promote breast cancer metastasis
Coffelt, S. B., Kersten, K., Doornebal, C. W., Weiden, J., Vrijland, K., Hau, C.-S., Verstegen, N. J. M., Ciampricotti, M., Hawinkels, L. J. A. C., Jonkers, J., et al. (2015) · Nature · doi:10.1038/nature14282 · Cited by 1,703
Mittal, D., Gubin, M. M., Schreiber, R. D., & Smyth, M. J. (2014) · Current Opinion in Immunology · doi:10.1016/j.coi.2014.01.004 · Cited by 1,471
Immune adaptations that maintain homeostasis with the intestinal microbiota
Hooper, L. V., & Macpherson, A. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2710 · Cited by 1,454
Six-of-the-best: unique contributions of γδ T cells to immunology
Vantourout, P., & Hayday, A. (2013) · Nature Reviews Immunology · doi:10.1038/nri3384 · Cited by 1,232
Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICA and MICB
Groh, V., Rhinehart, R., Secrist, H., Bauer, S., Grabstein, K. H., & Spies, T. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.6879 · Cited by 1,028
Research works printed but not linked: 1
- Gu, S., Nawrocka, W. & Adams, E. J. Sensing of pyrophosphate metabolites by Vγ9Vδ2 T cells. Front. Immunol. 5, 688 (2014).
Cited by
Inflammation and tumor progression: signaling pathways and targeted intervention
Zhao, H., Wu, L., Yan, G., Chen, Y., Zhou, M., Wu, Y., & Li, Y. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00658-5 · Cited by 2,792
Interferon-Gamma at the Crossroads of Tumor Immune Surveillance or Evasion
Castro, F., Cardoso, A. P., Gonçalves, R. M., Serre, K., & Oliveira, M. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00847 · Cited by 1,224
Self-citationGuidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)
Cossarizza, A., Chang, H., Radbruch, A., Acs, A., Adam, D., Adam‐Klages, S., Agace, W. W., Aghaeepour, N., Akdis, M., Allez, M., et al. (2019) · European Journal of Immunology · doi:10.1002/eji.201970107 · Cited by 979
Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
Jin, C., Lagoudas, G. K., Zhao, C., Bullman, S., Bhutkar, A., Hu, B., Ameh, S., Sandel, D., Liang, X. S., Mazzilli, S., et al. (2019) · Cell · doi:10.1016/j.cell.2018.12.040 · Cited by 964
Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition)
Cossarizza, A., Chang, H., Radbruch, A., Abrignani, S., Addo, R., Akdis, M., Andrä, I., Andreata, F., Annunziato, F., Arranz, E., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202170126 · Cited by 531
γδ T cells in homeostasis and host defence of epithelial barrier tissues
Nielsen, M. M., Witherden, D. A., & Havran, W. L. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.101 · Cited by 479
γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer
Silva-Santos, B., Mensurado, S., & Coffelt, S. B. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-019-0153-5 · Cited by 425
Self-citationTranslating gammadelta (γδ) T cells and their receptors into cancer cell therapies
Sebestyen, Z., Prinz, I., Déchanet-Merville, J., Silva-Santos, B., & Kuball, J. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0038-z · Cited by 425
Self-citationγδ T cells: origin and fate, subsets, diseases and immunotherapy
Hu, Y., Hu, Q., Li, Y., Lu, L., Xiang, Z., Yin, Z., Kabelitz, D., & Wu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01653-8 · Cited by 382
Iron Homeostasis in Health and Disease
Gozzelino, R., & Arosio, P. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17010130 · Cited by 359
The emerging roles of γδ T cells in cancer immunotherapy
Mensurado, S., Blanco-Domínguez, R., & Silva-Santos, B. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-022-00722-1 · Cited by 342
Self-citationUnconventional T Cell Targets for Cancer Immunotherapy
Godfrey, D. I., Le Nours, J., Andrews, D. M., Uldrich, A. P., & Rossjohn, J. (2018) · Immunity · doi:10.1016/j.immuni.2018.03.009 · Cited by 314
“Experimental transfer of established tumor cell lines derived from melanoma (Gao et al., 2003) and B cell lymphoma (Street et al., 2004) also confirmed a beneficial role of γδ T cells (reviewed in (Silva-Santos et al., 2015)).”
γδ T cells are effectors of immunotherapy in cancers with HLA class I defects
de Vries, N. L., van de Haar, J., Veninga, V., Chalabi, M., Ijsselsteijn, M. E., van der Ploeg, M., van den Bulk, J., Ruano, D., van den Berg, J. G., Haanen, J. B., et al. (2023) · Nature · doi:10.1038/s41586-022-05593-1 · Cited by 311
Immunobiology and immunotherapy of HCC: spotlight on innate and innate-like immune cells
Ruf, B., Heinrich, B., & Greten, T. F. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-00572-w · Cited by 312
Gamma-delta (γδ) T cells: friend or foe in cancer development?
Zhao, Y., Niu, C., & Cui, J. (2018) · Journal of Translational Medicine · doi:10.1186/s12967-017-1378-2 · Cited by 298
IL-17+ γδ T cells as kick-starters of inflammation
Papotto, P. H., Ribot, J. C., & Silva-Santos, B. (2017) · Nature Immunology · doi:10.1038/ni.3726 · Cited by 304
Self-citationMolecular classification and therapeutic targets in extrahepatic cholangiocarcinoma
Montal, R., Sia, D., Montironi, C., Leow, W. Q., Esteban-Fabró, R., Pinyol, R., Torres-Martin, M., Bassaganyas, L., Moeini, A., Peix, J., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.03.008 · Cited by 301
“Unlike the other molecular classes, we identified by virtual microdissection[38] high infiltration of gamma-delta T cells, known intraepithelial lymphocytes involved in the recognition of lipid antigens[39] (Fig.”
BackgroundDupraz, L., Magniez, A., Rolhion, N., Richard, M. L., Da Costa, G., Touch, S., Mayeur, C., Planchais, J., Agus, A., Danne, C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109332 · Cited by 274
Chae, Y. K., Chang, S., Ko, T., Anker, J., Agte, S., Iams, W., Choi, W. M., Lee, K., & Cruz, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-21061-1 · Cited by 253
Multifaceted Role of Neuropilins in the Immune System: Potential Targets for Immunotherapy
Roy, S., Bag, A. K., Singh, R. K., Talmadge, J. E., Batra, S. K., & Datta, K. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01228 · Cited by 240
Lawand, M., Déchanet-Merville, J., & Dieu-Nosjean, M.-C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00761 · Cited by 221
“Granzyme A produced by γ(9)δ(2) T cells induces human macrophages to inhibit growth of an intracellular pathogen.”
BackgroundAlmeida, A. R., Correia, D. V., Fernandes-Platzgummer, A., da Silva, C. L., da Silva, M. G., Anjos, D. R., & Silva-Santos, B. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0597 · Cited by 229
Self-citationThe human Vδ2+ T-cell compartment comprises distinct innate-like Vγ9+ and adaptive Vγ9- subsets
Davey, M. S., Willcox, C. R., Hunter, S., Kasatskaya, S. A., Remmerswaal, E. B. M., Salim, M., Mohammed, F., Bemelman, F. J., Chudakov, D. M., Oo, Y. H., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04076-0 · Cited by 228
TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy
Chiang, E. Y., & Mellman, I. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2022-004711 · Cited by 226
Gamma-Delta CAR-T Cells Show CAR-Directed and Independent Activity Against Leukemia
Rozenbaum, M., Meir, A., Aharony, Y., Itzhaki, O., Schachter, J., Bank, I., Jacoby, E., & Besser, M. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01347 · Cited by 218
“Lymphocytes bearing the γδT cell receptor (γδT) are a small subset of peripheral blood cytotoxic T cells, which do not require antigenic presentation by MHC molecules for recognition and function (9, 10).”
BackgroundNovel approaches to target the microenvironment of bone metastasis
Hofbauer, L. C., Bozec, A., Rauner, M., Jakob, F., Perner, S., & Pantel, K. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-021-00499-9 · Cited by 207
Gamma Delta T-Cell Based Cancer Immunotherapy: Past-Present-Future
Saura-Esteller, J., de Jong, M., King, L. A., Ensing, E., Winograd, B., de Gruijl, T. D., Parren, P. W. H. I., & van der Vliet, H. J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.915837 · Cited by 195
Lopes, N., McIntyre, C., Martin, S., Raverdeau, M., Sumaria, N., Kohlgruber, A. C., Fiala, G. J., Agudelo, L. Z., Dyck, L., Kane, H., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00848-3 · Cited by 197
Self-citationMIF-Dependent Control of Tumor Immunity
Noe, J. T., & Mitchell, R. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.609948 · Cited by 198
Tosolini, M., Pont, F., Poupot, M., Vergez, F., Nicolau-Travers, M.-L., Vermijlen, D., Sarry, J. E., Dieli, F., & Fournié, J.-J. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1284723 · Cited by 191
Novel therapeutic targets on the horizon for lung cancer
Tan, W.-L., Jain, A., Takano, A., Newell, E. W., Iyer, N. G., Lim, W.-T., Tan, E.-H., Zhai, W., Hillmer, A. M., Tam, W.-L., et al. (2016) · The Lancet Oncology · doi:10.1016/s1470-2045(16)30123-1 · Cited by 184
Li, L., Cao, B., Liang, X., Lu, S., Luo, H., Wang, Z., Wang, S., Jiang, J., Lang, J., & Zhu, G. (2019) · Oncogene · doi:10.1038/s41388-018-0627-z · Cited by 179
Distinctive features of tumor-infiltrating γδ T lymphocytes in human colorectal cancer
Meraviglia, S., Lo Presti, E., Tosolini, M., La Mendola, C., Orlando, V., Todaro, M., Catalano, V., Stassi, G., Cicero, G., Vieni, S., et al. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1347742 · Cited by 172
Cholesterol and beyond - The role of the mevalonate pathway in cancer biology
Göbel, A., Rauner, M., Hofbauer, L. C., & Rachner, T. D. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188351 · Cited by 164
Patil, R. S., Shah, S. U., Shrikhande, S. V., Goel, M., Dikshit, R. P., & Chiplunkar, S. V. (2016) · International Journal of Cancer · doi:10.1002/ijc.30134 · Cited by 159
Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer
Hoeres, T., Smetak, M., Pretscher, D., & Wilhelm, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00800 · Cited by 154
γδ T Cells: The Ideal Tool for Cancer Immunotherapy
Yazdanifar, M., Barbarito, G., Bertaina, A., & Airoldi, I. (2020) · Cells · doi:10.3390/cells9051305 · Cited by 162
“To date, the major obstacle to the broad application of γδ T cells for adoptive cell immunotherapy remains effective strategies of in vivo or ex vivo expansion [44,45].”
BackgroundThymic Determinants of γδ T Cell Differentiation
Muñoz‐Ruiz, M., Sumaria, N., Pennington, D. J., & Silva‐Santos, B. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.007 · Cited by 163
Self-citationKordbacheh, T., Honeychurch, J., Blackhall, F. H., Finn, C. F., & Illidge, T. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx790 · Cited by 151
Mikulak, J., Oriolo, F., Bruni, E., Roberto, A., Colombo, F. S., Villa, A., Bosticardo, M., Bortolomai, I., Lo Presti, E., Meraviglia, S., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125884 · Cited by 143
“Indeed, both Vδ1 and Vδ2 subsets expanded from peripheral blood are endowed with high antitumor activities against hematological malignances and solid tumors in vivo and in vitro (14).”
BackgroundSelf-citationTCR signal strength controls thymic differentiation of discrete proinflammatory γδ T cell subsets
Muñoz-Ruiz, M., Ribot, J. C., Grosso, A. R., Gonçalves-Sousa, N., Pamplona, A., Pennington, D. J., Regueiro, J. R., Fernández-Malavé, E., & Silva-Santos, B. (2016) · Nature Immunology · doi:10.1038/ni.3424 · Cited by 135
Self-citationGamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment
Gao, Z., Bai, Y., Lin, A., Jiang, A., Zhou, C., Cheng, Q., Liu, Z., Chen, X., Zhang, J., & Luo, P. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01722-0 · Cited by 138
“In contrast to αβT cells, γδT cells can recognize antigens in a way that is not restricted by major histocompatibility complex (MHC) molecules [6], and they mediate the killing of target cells in various ways, participate in immunomodulation, and have a broader tumor cell killing spectrum [7, 8].”
BackgroundTCR-Vγδ usage distinguishes protumor from antitumor intestinal γδ T cell subsets
Reis, B. S., Darcy, P. W., Khan, I. Z., Moon, C. S., Kornberg, A. E., Schneider, V. S., Alvarez, Y., Eleso, O., Zhu, C., Schernthanner, M., et al. (2022) · Science · doi:10.1126/science.abj8695 · Cited by 142
Acker, H. H. V., Anguille, S., Willemen, Y., den Bergh, J. M. J. V., Berneman, Z. N., Lion, E., Smits, E., & Tendeloo, V. F. V. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0329-3 · Cited by 142
Baci, D., Bosi, A., Gallazzi, M., Rizzi, M., Noonan, D. M., Poggi, A. D., Bruno, A., & Mortara, L. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093125 · Cited by 144
Human γδT-cell subsets and their involvement in tumor immunity
Wu, D., Wu, P., Qiu, F., Wei, Q., & Huang, J. (2017) · Cellular & Molecular Immunology · doi:10.1038/cmi.2016.55 · Cited by 123
Tan, L., Sandrock, I., Odak, I., Aizenbud, Y., Wilharm, A., Barros‐Martins, J., Tabib, Y., Borchers, A., Amado, T., Gangoda, L., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.05.064 · Cited by 131
Self-citationMensurado, S., Rei, M., Lança, T., Ιωάννου, Μ., Gonçalves‐Sousa, N., Kubo, H., Malissen, M., Papayannopoulos, V., Serre, K., & Silva‐Santos, B. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2004990 · Cited by 127
Self-citationResolution of Cancer-Promoting Inflammation: A New Approach for Anticancer Therapy
Zhang, Q., Zhu, B., & Li, Y. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00071 · Cited by 135
Interleukin‐17‐producing γδ T ( γδ 17) cells in inflammatory diseases
Akitsu, A., & Iwakura, Y. (2018) · Immunology · doi:10.1111/imm.12993 · Cited by 128
Vitamin C promotes the proliferation and effector functions of human γδ T cells
Kouakanou, L., Xu, Y., Peters, C., He, J., Wu, Y., Yin, Z., & Kabelitz, D. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0247-8 · Cited by 118
γδ T cell responses: How many ligands will it take till we know?
Vermijlen, D., Gatti, D., Kouzeli, A., Rus, T., & Eberl, M. (2018) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2017.10.009 · Cited by 125
CTLs heterogeneity and plasticity: implications for cancer immunotherapy
Peng, S., Lin, A., Jiang, A., Zhang, C., Zhang, J., Cheng, Q., Luo, P., & Bai, Y. (2024) · Molecular Cancer · doi:10.1186/s12943-024-01972-6 · Cited by 108
“Due to their ability to rapidly produce a variety of cytokines after activation, γδ T cells are involved in creating the first line of defense against infections and tumors [21, 22].”
Backgroundγδ T Cell-Mediated Immunity to Cytomegalovirus Infection
Khairallah, C. F., Déchanet‐Merville, J., & Capone, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00105 · Cited by 120
Escape from IFN-γ-dependent immunosurveillance in tumorigenesis
Lin, C.-F., Lin, C.-M., Lee, K.-Y., Wu, S.-Y., Feng, P.-H., Chen, K.-Y., Chuang, H.-C., Chen, C.-L., Wang, Y.-C., Tseng, P.-C., et al. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0317-0 · Cited by 110
Gherardin, N. A., Loh, L., Admojo, L., Davenport, A. J., Richardson, K., Rogers, A. J., Darcy, P. K., Jenkins, M. R., Prince, H. M., Harrison, S. J., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-22130-1 · Cited by 111
Anker, J. F., Naseem, A. F., Mok, H., Schaeffer, A. J., Abdulkadir, S. A., & Thumbikat, P. (2018) · Nature Communications · doi:10.1038/s41467-018-03900-x · Cited by 113
Liu, R., Hu, R., Zeng, Y., Zhang, W., & Zhou, H. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.102602 · Cited by 111
Avoidance of On-Target Off-Tumor Activation Using a Co-stimulation-Only Chimeric Antigen Receptor
Fisher, J. P. H., Abramowski, P., Don, N. D. W., Flutter, B. R., Capsomidis, A., Cheung, G. W.-K., Gustafsson, K. T., & Anderson, J. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.002 · Cited by 108
Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas
Daniels, J., Doukas, P. G., Escala, M. E. M., Ringbloom, K. G., Shih, D. J. H., Yang, J., Tegtmeyer, K., Park, J., Thomas, J. J., Selli, M. E., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15572-7 · Cited by 105
Mamedov, M. R., Scholzen, A., Nair, R. V., Cumnock, K., Kenkel, J. A., Oliveira, J. H. M., Trujillo, D. L., Saligrama, N., Zhang, Y., Rubelt, F., et al. (2018) · Immunity · doi:10.1016/j.immuni.2018.01.009 · Cited by 114
“…between gd T cells andmyeloid cells, while infections of gd T cell-deficient mice with Bordetella pertussis, Listeria monocytogenes, or Escherichia coli have shown dysfunctional myeloid recruitment (Shibata et al., 2007; Silva-Santos et al., 2015; Skeen et al., 2004; Zachariadis et al., 2006).”
Morandi, F., Yazdanifar, M., Cocco, C., Bertaina, A., & Airoldi, I. (2020) · Cells · doi:10.3390/cells9081757 · Cited by 106
“To date, the major obstacle to the broad application of NK and γδ T cells for adoptive cell immunotherapy remains effective strategies of in vivo or ex vivo expansion [14,15].”
BackgroundIL-38 Ameliorates Skin Inflammation and Limits IL-17 Production from γδ T Cells
Han, Y., Mora, J., Huard, A., da Silva, P., Wiechmann, S., Putyrski, M., Schuster, C., Elwakeel, E., Lang, G.-P., Scholz, A., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2019.03.082 · Cited by 113
CRISPR screens decode cancer cell pathways that trigger γδ T cell detection
Mamedov, M. R., Vedova, S., Freimer, J. W., Sahu, A. D., Ramesh, A., Arce, M. M., Meringa, A. D., Ota, M., Chen, P. A., Hanspers, K., et al. (2023) · Nature · doi:10.1038/s41586-023-06482-x · Cited by 109
The human fetal thymus generates invariant effector γδ T cells
Tieppo, P., Papadopoulou, M., Gatti, D., McGovern, N. N., Chan, J. K. Y., Gosselin, F., Goetgeluk, G., Weening, K., Ma, L., Dauby, N., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190580 · Cited by 104
“γδ T cells have been conserved since the emergence of jawed vertebrates >450 million years ago alongside B cells and αβ T cells and play an important role in antimicrobial and antitumor immunity (Hayday, 2000; Chien et al., 2014; Silva-Santos et al., 2015).”
BackgroundThe Dual Roles of Human γδ T Cells: Anti-Tumor or Tumor-Promoting
Li, Y., Li, G. L., Zhang, J., Wu, X., & Chen, X. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.619954 · Cited by 113
Innate and adaptive γδ T cells: How, when, and why
Papadopoulou, M., Sanchez, G. S., & Vermijlen, D. (2020) · Immunological Reviews · doi:10.1111/imr.12926 · Cited by 101
Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis
Li, N., Xu, W., Yuan, Y., Ayithan, N., Imai, Y., Wu, X., Miller, H., Olson, M., Feng, Y., Huang, Y. H., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01411-1 · Cited by 95
Strategies to enhance CAR-T persistence
Liu, Y., An, L., Huang, R., Xiong, J., Yang, H., Wang, X., & Zhang, X. (2022) · Biomarker Research · doi:10.1186/s40364-022-00434-9 · Cited by 97
“Regarding anticancer efficacy, γδT cells can kill target cells through the perforin-granzyme-B pathway, Fas-FasL pathway, and antibodydependent cell-mediated cytotoxicity (ADCC) pathway [66, 67].”
Backgroundγδ T Cells: Unexpected Regulators of Cancer Development and Progression
Fleming, C., Morrissey, S., Cai, Y., & Yan, J. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.06.003 · Cited by 97
γδ T cells in cancer immunotherapy
Zou, C., Zhao, P., Xiao, Z., Han, X., Fu, F., & Fu, L. (2017) · Oncotarget · doi:10.18632/oncotarget.13051 · Cited by 93
Wan, F., Hu, C., Ma, J.-X., Gao, K., Xiang, L., & Shao, J.-Z. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00675 · Cited by 97
“In contrast to conventional αβ T cells, γδ T cell repertoire is rather restricted because canonical γδ TCRs are expressed in specific anatomical locations (3).”
BackgroundXu, J., Yu, Y., Zhang, Y., Dai, H., Yang, Q., Wang, B., Ma, Q., Chen, Y., Xu, F., Shi, X., et al. (2024) · Nature Nanotechnology · doi:10.1038/s41565-024-01722-1 · Cited by 115
“30 and 31).”
InfluentialTherapeutic targeting of CK2 in acute and chronic leukemias
Buontempo, F., McCubrey, J. A., Orsini, E., Ruzzene, M., Cappellini, A., Lonetti, A., Evangelisti, C., Chiarini, F., Evangelisti, C., Barata, J. T., et al. (2017) · Leukemia · doi:10.1038/leu.2017.301 · Cited by 95
Human γδ T cells in diverse tissues exhibit site-specific maturation dynamics across the life span
Gray, J. I., Caron, D. P., Wells, S. B., Guyer, R. S., Szabo, P. A., Rainbow, D. B., Ergen, C., Rybkina, K., Bradley, M. C., Matsumoto, R., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.adn3954 · Cited by 102
The Ambiguous Role of γδ T Lymphocytes in Antitumor Immunity
Chitadze, G., Oberg, H., Wesch, D., & Kabelitz, D. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.06.004 · Cited by 92
γδ T cells in cancer: a small population of lymphocytes with big implications
Raverdeau, M., Cunningham, S., Harmon, C., & Lynch, L. (2019) · Clinical & Translational Immunology · doi:10.1002/cti2.1080 · Cited by 98
Mechanisms of Bacterial Superinfection Post-influenza: A Role for Unconventional T Cells
Paget, C., & Trottein, F. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00336 · Cited by 101
“The unique biologic features of unconventional T cells are now being harnessed in the fight against cancer (79, 110, 147).”
BackgroundDifferent T-cell subsets in glioblastoma multiforme and targeted immunotherapy
Wang, H., Zhou, H., Xu, J., Lu, Y., Ji, X., Yao, Y., Hou, C., Zhang, J., Zhang, X., Yao, S., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.09.028 · Cited by 100
Exhausted intratumoral Vδ2− γδ T cells in human kidney cancer retain effector function
Rancan, C., Arias-Badia, M., Dogra, P., Chen, B., Aran, D., Yang, H., Luong, D., Ilano, A., Li, J., Chang, H., et al. (2023) · Nature Immunology · doi:10.1038/s41590-023-01448-7 · Cited by 97
Cryoablation and Immunotherapy: An Enthralling Synergy to Confront the Tumors
Yakkala, C., Chiang, C. L.-L., Kandalaft, L., Denys, A., & Duran, R. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02283 · Cited by 88
Viral Infections in HSCT: Detection, Monitoring, Clinical Management, and Immunologic Implications
Annaloro, C., Serpenti, F., Saporiti, G., Galassi, G., Cavallaro, F., Grifoni, F. I., Goldaniga, M. C., Baldini, L., & Onida, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.569381 · Cited by 94
“Gamma-delta lymphocytes bear the potential of exerting an antineoplastic and antiviral activity, possibly without eliciting GVHD, thus arousing the interest about a possible role in CMV control (49).”
BackgroundRožman, P. J., & Švajger, U. (2018) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2018.04.001 · Cited by 95
T cell receptor signaling for γδT cell development
Muro, R., Takayanagi, H., & Nitta, T. (2019) · Inflammation and Regeneration · doi:10.1186/s41232-019-0095-z · Cited by 93
Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
Li, Y.-R., Halladay, T., & Yang, L. (2024) · Journal of Biomedical Science · doi:10.1186/s12929-024-00998-8 · Cited by 100
“Cell-based immunotherapies (CBIs) represent pio-neering paradigms in oncological intervention, harnessing the potential of the immune system to combat malignancies [1–4].”
BackgroundSquamous Cell Tumors Recruit γδ T Cells Producing either IL17 or IFNγ Depending on the Tumor Stage
Lo Presti, E., Toia, F., Oieni, S., Buccheri, S., Turdo, A., Mangiapane, L. R., Campisi, G., Caputo, V., Todaro, M., Stassi, G., et al. (2017) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-16-0348 · Cited by 83
TCR Sequencing Reveals the Distinct Development of Fetal and Adult Human Vγ9Vδ2 T Cells
Papadopoulou, M., Tieppo, P., McGovern, N. N., Gosselin, F., Chan, J. K. Y., Goetgeluk, G., Dauby, N., Cogan, A., Donner, C., Ginhoux, F., et al. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1900592 · Cited by 88
Fetal public Vγ9Vδ2 T cells expand and gain potent cytotoxic functions early after birth
Papadopoulou, M., Dimova, T., Shey, M. S., Briel, L., Veldtsman, H., Khomba, N., Africa, H., Steyn, M., Hanekom, W. A., Scriba, T. J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922595117 · Cited by 85
From thymus to periphery: Molecular basis of effector γδ‐T cell differentiation
Fiala, G. J., Gomes, A. Q., & Silva‐Santos, B. (2020) · Immunological Reviews · doi:10.1111/imr.12918 · Cited by 91
Self-citationTranslating Mouse Models: Immune Variation and Efficacy Testing
Sellers, R. S. (2017) · Toxicologic Pathology · doi:10.1177/0192623316675767 · Cited by 77
B7-H3 inhibits the IFN-γ-dependent cytotoxicity of Vγ9Vδ2 T cells against colon cancer cells
Lu, H., Shi, T., Wang, M., Li, X., Gu, Y., Zhang, X., Zhang, G., & Chen, W. (2020) · OncoImmunology · doi:10.1080/2162402x.2020.1748991 · Cited by 82
“Agrowing body of evidence indicates that activated γδTcells exert cytotoxic effects against tumor cells through the granzyme B/ perforin pathway.(37) We further explored whether the role of B7H3 inmodulating the cytotoxic potential ofVδ2T cells is perforin/ granzyme B pathway-dependent.”
BackgroundThe Role of Human γδ T Cells in Anti-Tumor Immunity and Their Potential for Cancer Immunotherapy
Liu, Y., & Zhang, C. (2020) · Cells · doi:10.3390/cells9051206 · Cited by 92
“The earliest discovery is that Vγ9Vδ2 T cells can specifically recognize non-peptide phosphoantigen, such as IPP, with a γδ TCR-dependent manner [42] (Figure 1).”
Backgroundγδ T Cells in the Tumor Microenvironment—Interactions With Other Immune Cells
Chan, K. F., Duarte, J. D. G., Ostrouska, S., & Behren, A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.894315 · Cited by 90
Current Advances in γδ T Cell-Based Tumor Immunotherapy
Lo Presti, E., Pizzolato, G., Gulotta, E., Cocorullo, G., Gulotta, G., Dieli, F., & Meraviglia, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01401 · Cited by 78
Double-edged effects of interferons on the regulation of cancer-immunity cycle
Zhang, X., Wang, S., Zhu, Y., Zhang, M., Zhao, Y., Yan, Z., Wang, Q., & Li, X. (2021) · OncoImmunology · doi:10.1080/2162402x.2021.1929005 · Cited by 85
Recognition of the antigen-presenting molecule MR1 by a Vδ3 + γδ T cell receptor
Rice, M. T., von Borstel, A., Chevour, P., Awad, W., Howson, L. J., Littler, D. R., Gherardin, N. A., Nours, J. L., Giles, E. M., Berry, R., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2110288118 · Cited by 78
Human γδ T-Cells: From Surface Receptors to the Therapy of High-Risk Leukemias
Pistoia, V., Tumino, N., Vacca, P., Veneziani, I., Moretta, A., Locatelli, F., & Moretta, L. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00984 · Cited by 78
Targeting distinct myeloid cell populations in vivo using polymers, liposomes and microbubbles
Ergen, C., Heymann, F., Rawashdeh, W. A., Gremse, F., Bartneck, M., Panzer, U., Pola, R., Pechar, M., Storm, G., Mohr, N., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.11.009 · Cited by 77
Espinoza, J. L., Trung, L. Q., Inaoka, P. T., Yamada, K., An, D. T. T., Mizuno, S., Nakao, S., & Takami, A. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/6781872 · Cited by 78
“γδ T cells constitute a heterogeneous T-cell subset with important roles in tumor surveillance, as demonstrated by their protective role during tumor development in various mouse cancer models [23, 26].”
BackgroundFacchin, S., Calgaro, M., & Savarino, E. V. (2025) · Cells · doi:10.3390/cells14151130 · Cited by 82
“However, they may induce inflammation in an unclear manner in chronic intestinal inflammation [63,64], while simultaneously promoting progression to colorectal cancer [65,66].”
Metadata
- Authors
- Silva-Santos, B., Serre, K., & Norell, H.
- Affiliations
- University of Lisbon (PT)
- Corresponding author
- Serre, Karine
- Venue
- Nature reviews. Immunology
- Published
- 2015-10-09
- Volume
- 15
- Issue
- 11
- Pages
- 683-691
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W2183777144
- Cited by
- 565
- References
- 95
- Citations by year
- 2026: 30 · 2025: 43 · 2024: 39 · 2023: 60 · 2022: 72 · 2021: 59 · 2020: 63 · 2019: 54 · 2018: 55 · 2017: 56 · 2016: 33
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Keywords
- γδ T cells, cancer immunotherapy, tumour immunity, cytotoxicity, interferon-gamma, IL-17, T cell regulation
- MeSH terms
- Animals, Cytotoxicity, Immunologic, Humans, Neoplasms, T-Lymphocytes, Receptors, Antigen, T-Cell, gamma-delta, Interleukin-17, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.